The Ophthalmic Market Trends: Quarterly US Retina Editions offer in-depth, quarterly insights into the ever-evolving US retina market. By surveying retina specialists and analyzing key metrics, these reports provide valuable data on retinal patient care, product usage, market share, and emerging trends. Each edition covers critical aspects such as IVT injections, DME treatments, vitrectomy volumes, and the adoption of both surgical equipment and pharmaceuticals like Eylea, Lucentis, and Avastin. With detailed trend analysis, full-year forecasts, and year-over-year comparisons, these editions are essential for making informed decisions and staying ahead in the retina care market.
The Ophthalmic Market Trends: Quarterly US Retina Editions measure and analyze key metrics of the US retinal market four times per year, including:
Our updates include trend analysis based on comparisons with information gathered in previous years. We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year.
Beyond survey data, Market Scope sources additional information from our proprietary disease models, database of refractive and cataract specialists, primary research, and public data sources. In some cases, this additional information is used to extrapolate survey data to total market estimates.
All Market Scope reports are continuously updated, and we appreciate your feedback at any time. If you have any questions or suggestions for improvements, please contact us.
2 licensing types are available for this subscription:
SINGLE USER LICENSE
ENTERPRISE LICENSE
Pay by credit card or by invoice.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.